Yun Yen MD

Oncology•Duarte, CA

Academic practice

Join to View Full Profile

1500 Duarte RdDuarte, CA 91010
Phone+1 626-359-8111
Fax+1 626-408-3911

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
St Luke's University HospitalResidency, Internal Medicine, 1987 - 1990
Taipei Medical UniversityClass of 1982

Certifications & Licensure

CA State Medical License 1989 - 2026
CT State Medical License 1990 - 1993

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Oxaliplatin in Treating Patients With Liver Cancer Start of enrollment: 2002 Sep 01
Completed
Phase 2
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors Start of enrollment: 2006 May 01
Completed
Phase 1, Phase 2
3-AP in Treating Patients With Advanced or Metastatic Solid Tumors Start of enrollment: 2006 Dec 01
Completed
Phase 1
High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer Start of enrollment: 2006 Apr 01
Completed
Phase 1
Safety Study of CALAA-01 to Treat Solid Tumor Cancers Start of enrollment: 2008 May 01
Terminated
Phase 1
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer Start of enrollment: 2014 Jun 11
Completed
Phase 1
A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer Start of enrollment: 2006 Nov 01
Terminated
Phase 2
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC) Start of enrollment: 2020 Jan 10
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

Mechanisms of reduced efficacy of HER2-targeted therapy in HER2-low breast cancer by long-term nicotine exposure in patient-derived xenograft mouse tumor models.
Yu-Hsuan Lin, Yuan-Soon Ho, Bu-Miin Huang, You-Cheng Liao, Tzu-Chun Cheng
Ecotoxicology and Environmental Safety. 2025-04-01
HERV Modulation in Colorectal Carcinoma Patients: A Snapshot of Endogenous Retroviral Transcriptome.
Nicole Grandi, Ching-Hsuan Liu, Saili Chabukswar, Daniele Carta, Yun Yen
Journal of Medical Virology. 2025-03-01
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.
Tzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, Shih-Hsin Tu, Chih-Hsiung Wu
Biomarker Research. 2025-01-09

Press Mentions

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine ResearchNovember 27th, 2021

Other Languages

Chinese (Mandarin)